Pädiatrie up2date, Inhaltsverzeichnis Pädiatrie up2date 2012; 07(02): 163-185DOI: 10.1055/s-0032-1309831 Varia © Georg Thieme Verlag KG Stuttgart · New YorkHauterkrankungen des Säuglings Lisa Weibel , Martin Theiler , Laurence FeldmeyerArtikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Volltext Referenzen Literatur 1 Landolt B, Staubli G, Lips U et al. Skin disorders encountered in a Swiss pediatric emergency department. Im Druck 2 Auvin S, Imiela A, Catteau B et al. Paediatric skin disorders encountered in an emergency hospital facility: a prospective study. Acta Derm Venereol 2004; 84: 451-454 3 Höger PH Hrsg. Kinderdermatologie. Differenzialdiagnose und Therapie bei Kindern und Jugendlichen. Stuttgart: Schattauer; 2011 4 Sterry W, Burgdorf W, Paus R Hrsg. Checkliste Dermatologie. 6. Aufl. Stuttgart: Thieme; 2010 5 Altmeyer P, Buhles N, Bacharach-Buhles M. Springer-Enzyklopädie Dermatologie, Allergologie, Umweltmedizin. Berlin: Springer; 2002 6 Frieden IJ, Haggstrom AN, Drolet BA et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. April 7–9, 2005, Bethesda, Maryland. Ped Dermatol 2005; 22: 383-406 7 Weibel L. Vascular anomalies in children. VASA 2011; 40 (06) 439-447 8 Sans V, de la Roque ED, Berge J et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124 (03) 423-431 9 Schiestl C, Neuhaus K, Zoller S et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011; 170 (04) 493-501 10 Chakkittakandiyil A, Phillips R, Frieden IJ et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012; 29 (01) 28-31 11 Mazereeuw-Hautier J, Syed S, Harper JI. Bilateral facial capillary malformation associated with eye and brain abnormalities. Arch Dermatol 2006; 142: 994-998 12 Ashinoff R, Gernonemus RG. Flashlamp-pumped pulsed dye laser for port-wine stains in infancy: earlier versus later treatment. J Am Acad Dermatol 1991; 24: 467-472 13 Hautschild A, Garbe C, Bauer J et al. Leitlinie melanozytäre Nävi. J Dtsch Dermatol Ges 2006; 4: 686-697 14 Kinsler VA, Chong WK, Aylett SE et al. Complications of congenital melanocytic naevi in children: analysis of 16 years experience and clinical practice. Br J Dermatol 2008; 159: 907-914 15 Krengel S, Hautschild A, Schäfer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 2006; 155: 1-8 16 Marghoob AA, Agero ALC, Benevnuto-Andrade C et al. Large congenital melanocytic nevi, risk of cutaneous melanoma and prophylactic surgery. J Am Acad Dermatol 2006; 54: 868-870 17 Kinsler V, Bulstrode N. The role in the management of congenital melanocytic naevi in children: a perspective from Great Ormond Street Hospital. J Plast Reconstr Aesthet Surg 2009; 62 (05) 595-601 18 Kienast A, Roth B, Bossier C et al. Zinc-deficiency dermatitis in breast-fed infants. Eur J Pediatr 2007; 166: 189-194 19 Tilles G, Wallach D, Taieb A. Topical therapy of atopic dermatitis: controversies from Hippocrates to topical immunomodulators. J Am Acad Dermatol 2007; 56: 295-301 20 Hamm H, Beiteke U, Hoeger PH et al. Treatment of scabies with 5% Permethrin cream: results of a German multicenter study. J Dtsch Dermatol Ges 2006; 4: 407-413 21 Bodemer C, Hermine O, Palmérini F et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130: 804-815